TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
June 24, 2026
“TRAIL-R2 is also a key mediator of apoptosis but its clinical implications and epigenetic regulation in breast cancer are not clearly understood.” BUFFALO, NY - June 24, 2026 – A… read more